Northern Trust’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.44M | Sell |
653,533
-46,784
| -7% | -$533K | ﹤0.01% | 2231 |
|
|
2025
Q1 | $8.32M | Buy |
700,317
+40,529
| +6% | +$481K | ﹤0.01% | 2149 |
|
|
2024
Q4 | $12.4M | Buy |
659,788
+92,933
| +16% | +$1.75M | ﹤0.01% | 1999 |
|
|
2024
Q3 | $12.7M | Buy |
566,855
+128,766
| +29% | +$2.89M | ﹤0.01% | 1925 |
|
|
2024
Q2 | $9.14M | Buy |
438,089
+34,079
| +8% | +$711K | ﹤0.01% | 2050 |
|
|
2024
Q1 | $5.94M | Sell |
404,010
-12,804
| -3% | -$188K | ﹤0.01% | 2354 |
|
|
2023
Q4 | $4.3M | Sell |
416,814
-24,038
| -5% | -$248K | ﹤0.01% | 2587 |
|
|
2023
Q3 | $3.47M | Buy |
440,852
+12,210
| +3% | +$96K | ﹤0.01% | 2651 |
|
|
2023
Q2 | $4.28M | Buy |
428,642
+28,624
| +7% | +$286K | ﹤0.01% | 2587 |
|
|
2023
Q1 | $3.55M | Sell |
400,018
-7,925
| -2% | -$70.4K | ﹤0.01% | 2659 |
|
|
2022
Q4 | $4.48M | Buy |
407,943
+4,201
| +1% | +$46.1K | ﹤0.01% | 2549 |
|
|
2022
Q3 | $5.26M | Buy |
403,742
+15,548
| +4% | +$203K | ﹤0.01% | 2456 |
|
|
2022
Q2 | $4.92M | Buy |
388,194
+83,657
| +27% | +$1.06M | ﹤0.01% | 2522 |
|
|
2022
Q1 | $4.27M | Sell |
304,537
-11,484
| -4% | -$161K | ﹤0.01% | 2672 |
|
|
2021
Q4 | $9.15M | Sell |
316,021
-4,985
| -2% | -$144K | ﹤0.01% | 2296 |
|
|
2021
Q3 | $9.62M | Buy |
321,006
+24,116
| +8% | +$723K | ﹤0.01% | 2302 |
|
|
2021
Q2 | $7.88M | Buy |
296,890
+64,213
| +28% | +$1.7M | ﹤0.01% | 2538 |
|
|
2021
Q1 | $7.23M | Buy |
232,677
+94,865
| +69% | +$2.95M | ﹤0.01% | 2510 |
|
|
2020
Q4 | $4.53M | Buy |
137,812
+4,474
| +3% | +$147K | ﹤0.01% | 2733 |
|
|
2020
Q3 | $4.65M | Buy |
+133,338
| New | +$4.65M | ﹤0.01% | 2573 |
|